Skip to content

IMNM · Immunome Inc.

Healthcare · −5.3% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 9 feeds behind: FDA drug approvals, 4 days, and 8 more · Every feed →

On this page

The market view

Price chart

The interactive IMNM chart (by TradingView) loads here.

Our take

4 rules fired on IMNM

In short: none of these rules has solid or some evidence yet, so they show no clear lean on IMNM.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

All 4 rules
The 0–100 score for IMNM, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on IMNM, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of IMNM. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 24, 2026–Oct 21, 2026 · UTC dates · today is excluded

Insider purchases

Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
0
Earlier median
0
Earlier range
0–0
Distinct filers per 28 daysScale: 0–1
Oct 23, 2025Oct 21, 2026
Earlier periodsLatest 28 daysEarlier median 0Limited or missing history

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 17, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 20260Partial; excluded
Jul 2, 2026–Jul 29, 20260Within stored history
Jul 30, 2026–Aug 26, 20260Within stored history
Aug 27, 2026–Sep 23, 20260Within stored history
Sep 24, 2026–Oct 21, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 2; range: 1–3.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 20262Partial; excluded
Jul 2, 2026–Jul 29, 20263Within stored history
Jul 30, 2026–Aug 26, 20262Within stored history
Aug 27, 2026–Sep 23, 20261Within stored history
Sep 24, 2026–Oct 21, 2026Latest period0Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 2026—Unavailable
Jul 2, 2026–Jul 29, 2026—Unavailable
Jul 30, 2026–Aug 26, 2026—Unavailable
Aug 27, 2026–Sep 23, 2026—Unavailable
Sep 24, 2026–Oct 21, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 2026—Unavailable
Jul 2, 2026–Jul 29, 2026—Unavailable
Jul 30, 2026–Aug 26, 2026—Unavailable
Aug 27, 2026–Sep 23, 2026—Unavailable
Sep 24, 2026–Oct 21, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

Company filings · Oct 2026

  1. Filed
  2. Record date
    FDA warning letter ↗

    8-K · mentioned before

  3. Filed
  4. Filed
All 31 records in this snapshot
  1. Filed
  2. Record date
    FDA warning letter ↗

    8-K · mentioned before

  3. Filed
  4. Filed
  5. Disclosed
    Jack Higgins · Sale

    Transaction dated Sep 11, 2026

  6. Filed
  7. Disclosed
    Isaac Barchas · Sale

    Transaction dated Aug 11, 2026

  8. Disclosed
    Isaac Barchas · Sale

    Transaction dated Aug 10, 2026

  9. Disclosed
    Isaac Barchas · Sale

    Transaction dated Aug 12, 2026

  10. Filed
  11. Filed
  12. Filed
  13. Disclosed
    Isaac Barchas · Sale

    Transaction dated Aug 6, 2026

  14. Disclosed
    Isaac Barchas · Sale

    Transaction dated Aug 7, 2026

  15. Disclosed
    Kinney Horn · Sale

    Transaction dated Aug 4, 2026

  16. Filed
  17. Filed
  18. Disclosed
    Kinney Horn · Sale

    Transaction dated Jul 7, 2026

  19. Disclosed
    Isaac Barchas · Sale

    Transaction dated Jul 6, 2026

  20. Disclosed
    Isaac Barchas · Sale

    Transaction dated Jul 7, 2026

  21. Filed
  22. Disclosed
    Robert Lechleider · Sale

    Transaction dated Jul 2, 2026

  23. Disclosed
    Robert Lechleider · Sale

    Transaction dated Jul 2, 2026

  24. Disclosed
    Robert Lechleider · Sale

    Transaction dated Jul 2, 2026

  25. Disclosed
    Isaac Barchas · Sale

    Transaction dated Jun 30, 2026

  26. Disclosed
    Isaac Barchas · Sale

    Transaction dated Jul 2, 2026

  27. Disclosed
    Isaac Barchas · Sale

    Transaction dated Jul 2, 2026

  28. Disclosed
    Robert Lechleider · Sale

    Transaction dated Jun 25, 2026

  29. Disclosed
    Robert Lechleider · Sale

    Transaction dated Jun 25, 2026

  30. Disclosed
    Max Rosett · Sale

    Transaction dated Jun 15, 2026

  31. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on IMNM disclosed in the last 90 days.

See every Congress trade on IMNM →

Company insiders

0 buys · 4 sells (7 filed lots) · $5.7M sold

  1. ▼ SELLJack Higgins Chief Scientific OfficerIMNM Immunome Inc.$334Kdisclosed Sep 15 · filed 4 days after the trade
  2. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$1.6Mdisclosed Aug 12 · filed 1 day after the trade
  3. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$264Kdisclosed Aug 12 · filed 2 days after the trade
  4. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$301Kdisclosed Aug 12 · filed the same day
  5. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$543Kdisclosed Aug 10 · filed 4 days after the trade
  6. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$397Kdisclosed Aug 10 · filed 3 days after the trade
  7. ▼ SELLKinney Horn Chief Business OfficerIMNM Immunome Inc.$2.3Mdisclosed Aug 6 · filed 2 days after the trade
See every insider trade on IMNM →

Filings & events

Company filings (8-K) 76

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Quarterly or yearly results · item 2.0211
  • Other events · item 8.019
  • Directors or officers joined, left or got new pay · item 5.027
  • Signed a major agreement · item 1.016
  • Sold shares privately · item 3.026
  • Shared information with investors · item 7.015

Filing red flags 22

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 1

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

Planned insider sales (Form 144) 18

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

4 in the last 90 days · 18 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 7

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 2 filings
  • 13G, just holds: 5 filings

Filed by Sirenia Capital Management LP · Enavate Sciences GP, LLC · T. Rowe Price Investment Management, Inc. · Fmr LLC

Biggest named funds (13F)

The largest IMNM holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on IMNM

  1. ▼ SELLJack Higgins Chief Scientific OfficerIMNM Immunome Inc.$334Kdisclosed Sep 15 · filed 4 days after the trade
  2. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$1.6Mdisclosed Aug 12 · filed 1 day after the trade
  3. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$264Kdisclosed Aug 12 · filed 2 days after the trade
  4. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$301Kdisclosed Aug 12 · filed the same day
  5. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$543Kdisclosed Aug 10 · filed 4 days after the trade
  6. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$397Kdisclosed Aug 10 · filed 3 days after the trade
  7. ▼ SELLKinney Horn Chief Business OfficerIMNM Immunome Inc.$2.3Mdisclosed Aug 6 · filed 2 days after the trade
  8. ▼ SELLKinney Horn Chief Business OfficerIMNM Immunome Inc.$27.3Kdisclosed Jul 9 · filed 2 days after the trade
  9. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$2Mdisclosed Jul 7 · filed 1 day after the trade
  10. ▼ SELLRobert Lechleider Chief Medical OfficerIMNM Immunome Inc.$377Kdisclosed Jul 7 · filed 5 days after the trade · late
  11. ▼ SELLRobert Lechleider Chief Medical OfficerIMNM Immunome Inc.$499Kdisclosed Jul 7 · filed 5 days after the trade · late
  12. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$409Kdisclosed Jul 7 · filed the same day
  13. ▼ SELLRobert Lechleider Chief Medical OfficerIMNM Immunome Inc.$369Kdisclosed Jul 7 · filed 5 days after the trade · late
  14. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$2.1Mdisclosed Jul 2 · filed 2 days after the trade
  15. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$1.7Mdisclosed Jul 2 · filed the same day
  16. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$568Kdisclosed Jul 2 · filed the same day
  17. ▼ SELLRobert Lechleider Chief Medical OfficerIMNM Immunome Inc.$298Kdisclosed Jun 29 · filed 4 days after the trade
  18. ▼ SELLRobert Lechleider Chief Medical OfficerIMNM Immunome Inc.$794Kdisclosed Jun 29 · filed 4 days after the trade
  19. ▼ SELLMax Rosett Chief Financial OfficerIMNM Immunome Inc.$1.1Mdisclosed Jun 17 · filed 2 days after the trade
See the trades on IMNM in the feed →
People & votes

Which members of Congress traded IMNM, sponsored bills that touch it and voted on them — opens here.